Stockscreener 앱 받기
97.92
2.76%
-2.78
시간 외 거래:
98.06
0.14
+0.14%
전일 마감가:
$100.70
열려 있는:
$100.47
하루 거래량:
15.31M
Relative Volume:
1.52
시가총액:
$251.88B
수익:
$63.17B
순이익/손실:
$12.15B
주가수익비율:
20.53
EPS:
4.77
순현금흐름:
$14.84B
1주 성능:
-1.34%
1개월 성능:
-2.14%
6개월 성능:
-22.22%
1년 성능:
-17.11%
1일 변동 폭
$97.92
$100.47
1주일 범위
$97.92
$101.49
52주 변동 폭
$94.48
$134.63
머크앤드컴퍼니 Stock (MRK) Company Profile
명칭
Merck Co Inc
전화
908-740-4000
주소
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
MRK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
97.92 | 251.88B | 63.17B | 12.15B | 14.84B | 4.77 |
|
LLY
Lilly Eli Co
|
725.72 | 689.73B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
78.69 | 349.44B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
147.03 | 344.63B | 87.70B | 14.68B | 19.03B | 6.05 |
|
ABBV
Abbvie Inc
|
171.56 | 303.17B | 55.53B | 5.12B | 15.62B | 2.88 |
머크앤드컴퍼니 Stock (MRK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-08 | 다운그레이드 | Truist | Buy → Hold |
| 2024-12-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | 재개 | BofA Securities | Buy |
| 2024-12-04 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-11 | 다운그레이드 | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-03-11 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2024-01-04 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-27 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | 업그레이드 | UBS | Neutral → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Hold |
| 2023-04-13 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-03-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-03-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 개시 | Jefferies | Buy |
| 2023-02-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-10-10 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-09-14 | 업그레이드 | Berenberg | Hold → Buy |
| 2022-07-06 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 재개 | SVB Leerink | Outperform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 개시 | Goldman | Buy |
| 2021-12-16 | 개시 | Daiwa Securities | Neutral |
| 2021-12-13 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-12-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-11-29 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-11-01 | 업그레이드 | Argus | Hold → Buy |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-20 | 다운그레이드 | Argus | Buy → Hold |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-08-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-06-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-16 | 개시 | SVB Leerink | Outperform |
| 2019-07-03 | 개시 | Mizuho | Buy |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-05-13 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 재확인 | Citigroup | Buy |
| 2018-10-09 | 재개 | Guggenheim | Buy |
| 2018-04-23 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-04-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-03-12 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-02-07 | 재확인 | Morgan Stanley | Equal-Weight |
| 2018-01-16 | 업그레이드 | SunTrust | Hold → Buy |
모두보기
머크앤드컴퍼니 주식(MRK)의 최신 뉴스
Merck: 3x Pipeline And Undervaluation Make It A Buy (NYSE:MRK) - Seeking Alpha
Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey
AHL Investment Management Inc. Invests $269,000 in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Annex Advisory Services LLC Trims Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Brady Martz Wealth Solutions LLC Acquires Shares of 17,939 Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Ameritas Advisory Services LLC - MarketBeat
Jim Cramer on Merck & Co., Inc. (MRK): ‘Right Now, The Stock’s Well-ensconced A Few Points Around 52-week Low’ - Insider Monkey
Folger Nolan Fleming Douglas Capital Management Inc. Has $6.91 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Wealth Alliance Advisory Group LLC Reduces Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Kera Capital Partners Inc. Purchases New Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Jackson Square Capital LLC Sells 15,684 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
HB Wealth Management LLC Increases Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Integrated Investment Consultants LLC Has $62.33 Million Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Holdings Lifted by Merit Financial Group LLC - MarketBeat
Arkadios Wealth Advisors Decreases Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Is Moderna Stock a Buy? - The Motley Fool
How Is Merck's Stock Performance Compared to Other Pharmaceuticals Stocks? - MSN
Is Merck & Co., Inc. (MRK) the Best Cheap Stock to Buy for 2025? - Insider Monkey
Exclusive: Kennedy played key role in Gardasil vaccine case against Merck - Reuters
Householder Group Estate & Retirement Specialist LLC Sells 4,613 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Relyea Zuckerberg Hanson LLC Purchases 3,131 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Hennessy Advisors Inc. Increases Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Bought by Carnegie Investment Counsel - MarketBeat
Yarger Wealth Strategies LLC Invests $252,000 in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Stock Price | MRK Stock Quote, News, and History - Markets Insider
Purdue teams with Lilly, Merck to launch pharma manufacturing initiative - Inside INdiana Business
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Guggenheim cuts Merck stock target, retains Buy on revised estimates - MSN
Drug Discovery Market Generated Opportunities, Future Scope by 2031 | Pfizer Inc., GlaxoSmithKline LLC, Merck - EIN News
KMG Fiduciary Partners LLC Acquires 14,161 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Empirical Asset Management LLC Raises Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Eagle Rock Investment Company LLC Sells 13,523 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stake Lessened by Salvus Wealth Management LLC - MarketBeat
Tallon Kerry Patrick Acquires Shares of 3,679 Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Gateway Investment Advisers LLC - MarketBeat
7MM Type 1 Diabetes Market Drug Forecast and Market Analysis 2023-2024 & 2033: Value to Reach $9.91 Billion - GlobeNewswire Inc.
Merck Defends 3rd Circ. Win In Mumps Vaccine Antitrust Case - Law360
Godsey & Gibb Inc. Acquires 9,571 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and Earnings Conference Call Feb. 4 - Business Wire
Campbell Newman Asset Management Inc. Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Wolff Wiese Magana LLC Acquires 4,633 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Founders Grove Wealth Partners LLC Buys New Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Assenagon Asset Management S.A. Sells 1,440,399 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Jim Cramer on Merck & Co., Inc. (MRK): ‘Down Very Badly’ - Insider Monkey
Who Are Pfizer's (PFE) Main Competitors? - Investopedia
Merck & Co., Inc. (NYSE:MRK) Stock Holdings Trimmed by Park Avenue Securities LLC - MarketBeat
Price Over Earnings Overview: Merck & Co - Benzinga
Pines Wealth Management LLC Buys New Shares in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Rockland Trust Co. Buys 30,562 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Horizon Bancorp Inc. IN Buys 9,938 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
머크앤드컴퍼니 (MRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.23%
자본화:
|
볼륨(24시간):